Zusammenfassung
Hintergrund
Im Zuge der technischen Verbesserungen im Bereich des Tissue Engineering erarbeiten diverse Arbeitsgruppen Alternativen zu konventionellen Methoden der Oberflächenrekonstruktion der Hornhaut. Dieses Bestreben entspringt der Not, dass die Amnionmembran als etablierte Biomatrix für die Oberflächenrekonstruktion wenig standardisiert hergestellt wird, hohen strukturellen Variationen unterliegt und nicht überall verfügbar ist.
Fragestellung
Es erfolgt eine Darlegung neuer Ansätze zur Rekonstruktion der Augenoberfläche mittels Membranen aus Kollagenen und aus bioverträglichen Polymeren.
Material und Methoden
Basierend auf einer Literaturrecherche wird ein Überblick über wesentliche Untersuchungsergebnisse zu kollagenen Biomatrizes an der Hornhautoberfläche gegeben. Zusätzlich werden eigene Erfahrungen mit neuartigen Biomatrizes für die Anwendung im Bereich der Hornhaut dargestellt.
Ergebnisse
Laborexperimentelle Arbeiten bestätigen den vorgestellten Materialien eine hohe Bioverträglichkeit und lassen ihre direkte Anwendung an der Hornhautoberfläche bei nicht heilenden Oberflächendefekten oder aber ihre Verwendung als Träger epithelialer Stammzellen für die Transplantation auf die Hornhaut auch am Menschen als vielversprechend erscheinen. Klinische Anwendungen biosynthetischer Biomatrizes im Bereich der Hornhaut sind jedoch im Klinikalltag bislang nicht etabliert, und auch klinische Studien gibt es nur vereinzelt.
Schlussfolgerung
Obgleich sich ein Großteil der vorgestellten Materialien im Wesentlichen in laborexperimentellen Stadien befindet, ist eine Translation in die Klinik denkbar und von hohem therapeutischem Interesse.
Abstract
Background
Amniotic membranes have been used for many years for reconstruction of the ocular surface. Despite having anti-inflammatory and antiangiogenic properties as well as being suitable as a carrier for corneal epithelial cells, amniotic membranes also have some limitations for use at the human cornea: availability is limited, there are major interindividual variations in structure and growth factor content and are not free from the risk of disease transmission. Progress in tissue engineering has been made aiming at the development and improvement of alternative biomaterials.
Objectives
This article presents new approaches for reconstruction of the corneal surface with collagen-based biomaterials and polymers.
Material and methods
Electronic databases were searched for articles which evaluated collagenous biomaterials for use at the corneal surface. In addition the authors’ own experiences with novel biomaterials are described.
Results
In vitro evaluation of the described biomaterials suggested a high biocompatibility with corneal epithelial cells in cell cultures. In vivo experiments with these materials in animal corneas demonstrated a certain variability in degradation and remodeling. Although some materials showed promising experimental results none of these are established in the clinical routine and only few clinical studies have so far been conducted with collagen-based biomaterials.
Conclusion
Although the majority of the described biomaterials are currently still in the experimental stage, a transfer into the clinical routine is conceivable and of great therapeutic interest.
Literatur
Meller D, Pauklin M, Thomasen H et al (2011) Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int 108:243–248
Hopkinson A, McIntosh RS, Tighe PJ et al (2006) Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci 47:4316–4322
Gicquel JJ, Dua HS, Brodie A et al (2009) Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs. Tissue Eng Part A 15:1919–1927
Connon CJ, Doutch J, Chen B et al (2010) The variation in transparency of amniotic membrane used in ocular surface regeneration. Br J Ophthalmol 94:1057–1061
Wong SC, Baji A, Leng S (2008) Effect of fiber diameter on tensile properties of electrospun poly(ɛ-caprolactone). Polymer 49:4713–4722
Baker BM, Handorf AM, Ionescu LC et al (2009) New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Rev Med Devices 6:515–532
Kenar H, Kose GT, Toner M et al (2011) A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 32:5320–5329
Ruberti JW, Zieske JD (2008) Prelude to corneal tissue engineering – gaining control of collagen organization. Prog Retin Eye Res 27:549–577
Ihanamaki T, Pelliniemi LJ, Vuorio E (2004) Collagens and collagen-related matrix components in the human and mouse eye. Prog Retin Eye Res 23:403–434
Qazi Y, Wong G, Monson B et al (2010) Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull 81:198–210
Builles N, Janin-Manificat H, Malbouyres M et al (2010) Use of magnetically oriented orthogonal collagen scaffolds for hemi-corneal reconstruction and regeneration. Biomaterials 31:8313–8322
Crabb RA, Chau EP, Evans MC et al (2006) Biomechanical and microstructural characteristics of a collagen film-based corneal stroma equivalent. Tissue Eng 12:1565–1575
Deshpande P, Ramachandran C, Sefat F et al (2013) Simplifying corneal surface regeneration using a biodegradable synthetic membrane and limbal tissue explants. Biomaterials 34:5088–5106
Liu Y, Gan L, Carlsson DJ et al (2006) A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci 47:1869–1875
Orwin EJ, Borene ML, Hubel A (2003) Biomechanical and optical characteristics of a corneal stromal equivalent. J Biomech Eng 125:439–444
Wu J, Du Y, Watkins SC et al (2012) The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells. Biomaterials 33:1343–1352
Rafat M, Li F, Fagerholm P et al (2008) PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering. Biomaterials 29:3960–3972
Hu X, Lui W, Cui L et al (2005) Tissue engineering of nearly transparent corneal stroma. Tissue Eng 11:1710–1717
Lawrence BD, Marchant JK, Pindrus MA et al (2009) Silk film biomaterials for cornea tissue engineering. Biomaterials 30:1299–1308
Schmitt FO, Levine L, Drake MP et al (1964) The antigenicity of tropocollagen. Proc Natl Acad Sci U S A 51:493–497
Staatz WD, Fok KF, Zutter MM et al (1991) Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 266:7363–7367
Gullberg D, Terracio L, Borg TK et al (1989) Identification of integrin-like matrix receptors with affinity for interstitial collagens. J Biol Chem 264:12686–12694
Gullberg D, Turner DC, Borg TK et al (1990) Different beta 1-integrin collagen receptors on rat hepatocytes and cardiac fibroblasts. Exp Cell Res 190:254–264
Geggel HS, Friend J, Thoft RA (1985) Collagen gel for ocular surface. Invest Ophthalmol Vis Sci 26:901–905
Dunn MW, Nishihara T, Stenzel KH et al (1967) Collagen-derived membrane: corneal implantation. Science 157:1329–1330
Payrau P, Offret G, Faure JP et al (1963) Experimental trial of the use of collagen in ophthalmology. Arch Ophtalmol Rev Gen Ophtalmol 23:129–142
Duan X, McLaughlin C, Griffith M et al (2007) Biofunctionalization of collagen for improved biological response: scaffolds for corneal tissue engineering. Biomaterials 28:78–88
Fagerholm P, Lagali NS, Carlsson DJ et al (2009) Corneal regeneration following implantation of a biomimetic tissue-engineered substitute. Clin Transl Sci 2:162–164
Simsek NA, Ay GM, Tugal-Tutkun I et al (1996) An experimental study on the effect of collagen shields and therapeutic contact lenses on corneal wound healing. Cornea 15:612–616
Groden LR, White W (1990) Porcine collagen corneal shield treatment of persistent epithelial defects following penetrating keratoplasty. CLAO J 16:95–97
Phinney RB, Schwartz SD, Lee DA et al (1988) Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol 106:1599–1604
Sawusch MR, O’Brien TP, Updegraff SA (1989) Collagen corneal shields enhance penetration of topical prednisolone acetate. J Cataract Refract Surg 15:625–628
Fagerholm P, Lagali NS, Merrett K et al (2010) A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci Transl Med 2 (46):46–61
Hackett JM, Lagali N, Merrett K et al (2011) Biosynthetic corneal implants for replacement of pathologic corneal tissue: performance in a controlled rabbit alkali burn model. Invest Ophthalmol Vis Sci 52:651–657
Liu W, Deng C, McLaughlin CR et al (2009) Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials 30:1551–1559
McLaughlin CR, Acosta MC, Luna C et al (2010) Regeneration of functional nerves within full thickness collagen-phosphorylcholine corneal substitute implants in guinea pigs. Biomaterials 31:2770–2778
Lagali NS, Griffith M, Shinozaki N et al (2007) Innervation of tissue-engineered corneal implants in a porcine model: a 1-year in vivo confocal microscopy study. Invest Ophthalmol Vis Sci 48:3537–3544
Petsch C, Schlotzer-Schrehardt U, Meyer-Blazejewska E et al (2014) Novel collagen membranes for the reconstruction of the corneal surface. Tissue Eng Part A 20(17–18):2378–2389
Petsch C, Schlötzer-Schrehardt U, Frey M et al (2013) Optimized culturing conditions for limbal epithelial cells cultivated on semi-synthetic collagen matrices. Invest Ophthalmol Vis Sci 54:E-Abstract 548
Torbet J, Malbouyres M, Builles N et al (2007) Orthogonal scaffold of magnetically aligned collagen lamellae for corneal stroma reconstruction. Biomaterials 28:4268–4276
Deng C, Li F, Hackett JM et al (2010) Collagen and glycopolymer based hydrogel for potential corneal application. Acta Biomater 6:187–194
Mi S, Chen B, Wright B et al (2010) Plastic compression of a collagen gel forms a much improved scaffold for ocular surface tissue engineering over conventional collagen gels. J Biomed Mater Res A 95:447–453
Levis HJ, Brown RA, Daniels JT (2010) Plastic compressed collagen as a biomimetic substrate for human limbal epithelial cell culture. Biomaterials 31:7726–7737
Fagerholm P, Lagali NS, Ong JA et al (2014) Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. Biomaterials 35:2420–2427
Gao J, Crapo P, Nerem R et al (2008) Co-expression of elastin and collagen leads to highly compliant engineered blood vessels. J Biomed Mater Res A 85:1120–1128
Redenti S, Neeley WL, Rompani S et al (2009) Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. BioMaterials 30:3405–3414
Sundback CA, Shyu JY, Wang Y et al (2005) Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials 26:5454–5464
Wang Y, Ameer GA, Sheppard BJ et al (2002) A tough biodegradable elastomer. Nat Biotechnol 20:602–606
Lee EJ, Vunjak-Novakovic G, Wang Y et al (2009) A biocompatible endothelial cell delivery system for in vitro tissue engineering. Cell Transplant 18:731–743
Salehi S, Bahners T, Gutmann JS et al (2014) Characterization of structural, mechanical and nano-mechanical properties of electrospun PGS/PCL fibers. RSC Adv 4:16951–16957
Salehi S, Fathi M, Javanmard SH et al (2014) Generation of PGS/PCL-blend nanofibrous scaffolds mimicking corneal stroma structure. Macromol Mat Eng 299:455–469
Byfield FJ, Reen RK, Shentu TP et al (2009) Endothelial actin and cell stiffness is modulated by substrate stiffness in 2D and 3D. J Biomech 42:1114–1119
Stevens MM, George JH (2005) Exploring and engineering the cell surface interface. Science 310:1135–1138
Kenawy ER, Layman JM, Watkins JR et al (2003) Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. Biomaterials 24:907–913
Salehi S, Gruenert AK, Bahners T et al (2014) New nanofibrous scaffold for corneal tissue engineering. Klin Monatsbl Augenheilkd 231(6):626–630
Einhaltung ethischer Richtlinien
Interessenkonflikt. T. Fuchsluger, S. Salehi, C. Petsch und B. Bachmann geben an, dass kein Interessenkonflikt besteht. Alle im vorliegenden Manuskript beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zuständigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patienten liegt eine Einverständniserklärung vor.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuchsluger, T., Salehi, S., Petsch, C. et al. Neue Möglichkeiten der Augenoberflächenrekonstruktion. Ophthalmologe 111, 1019–1026 (2014). https://doi.org/10.1007/s00347-013-3010-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-3010-z